Zenas BioPharma, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
ZBIO chart
What traders are saying about $ZBIO
Latest postsZenas BioPharma, Inc. news
- Zenas BioPharma to Present at the Jefferies London Global Healthcare Conference
Yahoo Finance ·
- Morgan Stanley Maintains Zenas BioPharma(ZBIO.US) With Hold Rating, Maintains Target Price $32
Moomoo ·
- Zenas BioPharma (ZBIO) After Third Quarter Losses Still Carries An Undervalued Narrative
Yahoo Finance ·
- Is Zenas BioPharma (ZBIO) Cheap As Wider Losses And A New Hire Stir Valuation Questions?
Simply Wall St ·
- Zenas BioPharma Launches New $200 Million Stock Offering
TipRanks ·
- Zenas BioPharma launches new $200 million at-the-market stock offering
Investing.com ·
- Zenas BioPharma Files New $200 Million At-the-Market Offering Supplement
TradingView ·
- Form 8K Zenas Biopharma Inc For: 6 November By Investing.com
Investing.com UK ·
- Zenas BioPharma (NasdaqGS:ZBIO) Stock Forecast & Analyst Predictions
Simply Wall St ·
- Zenas BioPharma Stock In Focus After Wider Quarterly Loss
Simply Wall St ·
- Zenas BioPharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
- Zenas BioPharma Eyes Key Lupus and IL-17 Data as Obexelimab FDA Decision Nears
marketbeat.com ·
Zenas BioPharma, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $10.0M | $5.0M | $50.0M |
| Net income | -$377.7M | -$157.0M | -$37.1M |
| Diluted EPS | $-8.44 | $-11.89 | $-24.25 |
| Total assets (year end) | $383.6M | $370.0M | $68.2M |
| Cash and equivalents (year end) | $110.6M | $319.7M | $56.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Zenas BioPharma, Inc.
- Ticker
- ZBIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1953926
- Former names
- Zenas BioPharma (Cayman) Ltd
Frequently asked questions
What exchange is Zenas BioPharma, Inc. listed on?
Zenas BioPharma, Inc. trades on the Nasdaq under the ticker symbol ZBIO.
What industry is Zenas BioPharma, Inc. in?
Zenas BioPharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Zenas BioPharma, Inc. headquartered?
Zenas BioPharma, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Zenas BioPharma, Inc.'s fiscal year end?
Zenas BioPharma, Inc.'s fiscal year ends on December 31.
How much revenue did Zenas BioPharma, Inc. report?
Zenas BioPharma, Inc. reported $10.0M in revenue for calendar year 2025, according to its SEC filings.